It can take up to 20 years of realworld data before we fully understand longterm safety profiles for any medication including GLP1s
Rahman Z, Kavanagh J, Champlin R, Giles R, Hanania E, Fu SQ, Zu Z, Mehra R, Holmes F, Kudelka A, Claxton D, Verschraegen C, Gajewski J, Andreeff M , Heimfeld S, Berenson R, Ellerson D, Calvert L, Dayn A, Holzmayer T, Hamer J, Bachier C, Ostrove J, Przepiorka D, Burtners B, Cote R, Bast R, Hortobagyi G, Deisseroth A
The addition of equimolar or higher concentrations of Cu 2+ to Htt induces oligomerization, along with the rapid reduction of Cu 2+ to Cu 1+ (Neupane et al., 2025)
Ongoing Research New studies are testing their impact on: Alzheimers disease Cardiovascular protection Inflammatory conditions These drugs might have more uses than we originally thought
Whether youre looking for more information or have specific inquiries, were ready to help you every step of the way